Search Results  for 'MVIRb.ST'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Medivir AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Jun 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Medivir AB

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

01 Jul 2015 Wright Reports 56 $75.00

Medivir AB: Downgraded to Above Average

19 Jun 2015 Sadif Analytics Prime 3 $10.00

Medivir AB (MVIR B) - Financial Analysis Review

Medivir AB (MVIR B) - Financial Analysis Review Summary Medivir AB (Medivir) is a bio-pharmaceutical company. The compa...

04 Jun 2015 GlobalData 46 $125.00

Medivir AB: An Alpha Deal Group Buy-Side Intelligence Brief

Medivir is a research based pharmaceutical company that develops and sells drugs for the treatment of infectious diseases, os...

28 May 2015 Alpha Deal Group Intelligence Brief 7 $50.00

MVIRb.ST - Event Transcript of Medivir AB conference call, May 05, 2015 / 6:30AM ET

Edited Event Transcript of MVIRb.ST conference call, May 05, 2015 / 6:30AM ET Boston, May 5, 2015 (Thomson StreetEvents...

05 May 2015 Thomson Reuters StreetEvents 10 $75.00

Company Snapshot - Medivir Ab

A director at Medivir Ab maiden bought 5,000 shares at 0.000SEK and the significance rating of the trade was 74/100. Is that...

31 Mar 2015 Directors Deals Ltd. 1 $12.00

MVIRb.ST - Event Transcript of Medivir AB conference call, Feb. 27, 2015 / 8:00AM ET

Edited Event Transcript of MVIRb.ST conference call, Feb. 27, 2015 / 8:00AM ET Boston, Feb 27, 2015 (Thomson StreetEven...

27 Feb 2015 Thomson Reuters StreetEvents 7 $75.00

Medivir AB: Upgraded to Good

06 Feb 2015 Sadif Analytics Prime 3 $10.00

Medivir AB (MVIR B) - Financial Analysis Review

Medivir AB (MVIR B) - Financial Analysis Review Summary Medivir AB (Medivir) is a bio-pharmaceutical company. The compa...

03 Feb 2015 GlobalData 47 $125.00